When to Refer Your Therapy Client for Psychiatric Medication: A Therapist’s Decision Guide

As a therapist, you became licensed to help people heal. You trained in evidence-based modalities, honed your clinical instincts, and built a practice grounded in the therapeutic relationship. But there are moments in treatment when you sense that something more is needed—when your client’s progress has plateaued, their symptoms have intensified, or the clinical picture has shifted in a way that psychotherapy alone cannot fully address.

Knowing when to refer a therapy client for psychiatric medication evaluation is one of the most consequential clinical decisions you will make. A well-timed referral can be the turning point in a client’s recovery. A delayed one can mean months of unnecessary suffering.

This guide is designed to help licensed therapists—LICSWs, LMHCs, LMFTs, and PsyDs—develop a structured framework for recognizing when medication consultation is warranted, how to approach the conversation with clients, and what to look for in a psychiatry partner for collaborative care.

Understanding the Split-Treatment Model

Before diving into referral criteria, it is important to understand the clinical framework that makes therapist-psychiatrist collaboration work: the split-treatment (or collaborative care) model.

In split-treatment, the therapist provides psychotherapy while a psychiatrist manages medication. Both clinicians maintain their own treatment relationship with the patient, communicate regularly about progress and concerns, and coordinate treatment planning. Research consistently demonstrates that this model produces superior outcomes for moderate-to-severe psychiatric conditions compared to either therapy or medication alone.

The split-treatment model is not about handing your client off. It is about expanding the treatment team to address biological dimensions of illness that psychotherapy cannot reach on its own. You remain the primary therapeutic relationship. The psychiatrist becomes a specialist consultant focused on neurochemistry, pharmacology, and medical differential diagnosis.

Seven Clinical Indicators That a Medication Referral Is Warranted

Not every client who is struggling needs medication. But certain clinical patterns should prompt a serious conversation about psychiatric evaluation. Here are seven evidence-informed indicators.

1. Functional Impairment Despite Adequate Therapy

Your client has been engaged in therapy for an appropriate duration (generally 8–12 sessions for CBT or similar structured modalities), has demonstrated effort and engagement, yet continues to experience significant functional impairment in work, relationships, or daily living. When a motivated client is not responding to a well-delivered, evidence-based intervention, the symptom burden may have a biological component that warrants pharmacological support.

2. Severity Escalation

Symptoms that were initially manageable have intensified. PHQ-9 scores are climbing. Your client with moderate depression is now reporting passive suicidal ideation. The generalized anxiety that once responded to grounding techniques is now producing daily panic attacks. Symptom escalation, especially when it outpaces therapeutic interventions, is a strong signal that medication evaluation should be prioritized.

3. Neurovegetative Symptoms

The hallmark signs that a psychiatric condition has a significant biological component include:

• Persistent insomnia or hypersomnia unresponsive to sleep hygiene interventions
• Significant appetite or weight changes (gain or loss of more than 5% body weight in a month)
• Psychomotor retardation or agitation observable in session
• Profound fatigue or loss of energy that limits daily functioning
• Difficulty concentrating that cannot be attributed to situational distress

When neurovegetative symptoms dominate the clinical picture, they often indicate dysregulation at a neurobiological level that medication can address more directly than psychotherapy.

4. Safety Concerns

This is the most urgent indicator. If your client presents with:

• Active suicidal ideation with plan or intent
• Self-harm behaviors that are escalating in frequency or severity
• Psychotic symptoms (hallucinations, delusions, disorganized thinking)
• Manic or hypomanic episodes with impaired judgment
• Severe dissociative episodes that compromise safety

These presentations require same-day or next-day psychiatric evaluation. Do not wait for the next scheduled session to initiate a referral. In cases of imminent danger, crisis services or emergency evaluation should be activated immediately.

5. Comorbid Conditions That Complicate Treatment

Many therapy clients present with comorbid diagnoses. When a client carries overlapping conditions—such as PTSD with comorbid major depressive disorder, ADHD with generalized anxiety, or bipolar disorder with substance use—the pharmacological nuance required to manage these interactions often exceeds what therapy alone can address. A psychiatrist trained in complex psychopharmacology can develop a medication strategy that accounts for the full diagnostic picture.

6. History of Prior Medication Response

If your client has a documented history of responding well to psychiatric medication in the past but discontinued treatment (due to cost, relapse, life transitions, or side effects), a re-evaluation with a psychiatrist is warranted. Prior positive medication response is one of the strongest predictors that pharmacotherapy will be beneficial again.

7. Family History of Psychiatric Illness

A strong family history of conditions like bipolar disorder, schizophrenia, or recurrent major depression suggests genetic loading that makes pharmacological intervention more likely to be necessary. While family history alone is not sufficient reason to refer, it should lower your threshold for recommending a medication evaluation when combined with other clinical indicators.

How to Talk to Your Client About a Medication Referral

Many therapists report that the hardest part of the referral process is not the clinical decision—it is the conversation. Clients may interpret a medication referral as a sign that therapy has failed, that something is fundamentally wrong with them, or that you are giving up.

Here is a framework for navigating this conversation effectively:

Normalize the Recommendation

Frame the referral as a standard part of comprehensive care, not a failure of therapy. For example: “What we’re working on together is important, and I want to make sure we’re giving you every tool available. A medication evaluation is something I recommend when I think it could help therapy work even better.”

Emphasize Continuity

Reassure the client that therapy will continue. A medication referral is an addition to treatment, not a replacement. The therapeutic relationship you have built remains central to their care.

Address Ambivalence Directly

Many clients have preexisting beliefs about psychiatric medication—fear of side effects, concerns about dependency, stigma, or negative experiences shared by friends or family. Use motivational interviewing techniques to explore ambivalence without pressuring the client. Acknowledge their concerns as valid while providing accurate information about what a medication evaluation involves (it is a conversation and an assessment, not a commitment to take medication).

Offer Specificity

A vague suggestion to “maybe see a psychiatrist” is easy for an ambivalent client to dismiss. Instead, provide a specific name, explain what the first appointment will look like, and offer to coordinate the referral yourself. Reducing logistical barriers dramatically increases follow-through.

What to Look for in a Psychiatry Partner

Not all psychiatrists are equally suited for collaborative care with therapists. When evaluating a potential referral partner, consider these factors:

Communication and Collaboration

The most important quality in a psychiatry partner is their willingness to communicate. A psychiatrist who returns your calls, responds to coordination requests in a timely manner, and proactively reaches out when medication changes are made is invaluable. Ask up front: How do you handle communication with referring therapists? What is your preferred method and frequency of contact?

Clinical Philosophy

Look for a psychiatrist who views medication as one tool in a comprehensive treatment plan, not a standalone solution. Psychiatrists who value psychotherapy and understand its role are far more likely to make medication decisions that complement your therapeutic work rather than undermine it.

Accessibility and Availability

Long wait times are the enemy of timely referrals. A client who needs a medication evaluation in two weeks should not wait three months. Telepsychiatry has significantly expanded access to psychiatric care, particularly in areas where in-person psychiatrists are scarce. A telehealth-based psychiatrist who can see your client within one to two weeks is often more clinically useful than an in-person provider with a four-month waitlist.

Diagnostic Rigor

You want a psychiatrist who conducts a thorough diagnostic assessment rather than prescribing based on a brief symptom checklist. This is especially important for complex presentations where misdiagnosis can lead to ineffective or harmful medication choices (for example, treating bipolar depression with an antidepressant alone, or prescribing benzodiazepines for panic disorder without ruling out substance use).

Respect for the Therapeutic Relationship

A good psychiatry partner will never undermine the therapy. They will reinforce the importance of continuing psychotherapy, defer to your expertise on psychosocial dynamics, and consult with you before making changes that might affect the therapeutic work (such as adding a sedating medication that could impair a client’s engagement in exposure therapy).

Building a Referral Workflow That Serves Your Clients

Effective referral is not a one-time event. It is a clinical workflow that should be built into your practice systems. Here are practical steps to streamline the process:

• Maintain a curated referral list. Identify two to three psychiatrists you trust and have communicated with directly. Vet them for the qualities described above before you need to make an urgent referral.
• Use standardized screening tools. Regular administration of the PHQ-9, GAD-7, PCL-5, or MDQ can provide objective data to support referral decisions and give the psychiatrist useful baseline information.
• Document your clinical reasoning. When you make a referral, document why in your treatment notes. This protects you clinically and legally, and it creates a clear record for the receiving psychiatrist.
• Establish a release of information early. Obtain a signed ROI for psychiatric coordination at intake or at the time of referral. This eliminates delays when communication becomes necessary.
• Schedule a follow-up session after the psychiatric evaluation. Debrief with your client after their first appointment with the psychiatrist. Address any concerns, reinforce the treatment plan, and begin integrating medication management into the therapy framework.

The Cost of Waiting Too Long

Therapists sometimes delay medication referrals out of a genuine belief that therapy should be given more time to work. This clinical conservatism is understandable and, in many cases, appropriate. But it can also become a liability.

Untreated or undertreated psychiatric symptoms do not simply persist—they often worsen. Depression that goes unmedicated for too long can become treatment-resistant. Anxiety disorders that are not adequately managed can generalize and expand. Clients lose jobs, relationships deteriorate, and the window of motivation for treatment can close.

The question is not whether your client will eventually need medication. The question is whether a medication evaluation now could accelerate their recovery and prevent unnecessary deterioration. When in doubt, refer. A skilled psychiatrist will decline to prescribe if medication is not indicated. But delaying the evaluation has no clinical upside.

A Note on the Current Landscape

Access to psychiatric care in Massachusetts remains challenging. Psychiatrist shortages, long waitlists, and insurance network limitations create real barriers for clients. However, the expansion of telehealth psychiatry since 2020 has created new pathways. Telepsychiatry allows clients to access medication management from their home, eliminates transportation barriers, and often provides shorter wait times than traditional in-person practices.

For therapists building their referral networks, considering telehealth psychiatry options—particularly those that emphasize collaborative care with therapists—can significantly improve access for your clients.

Key Takeaways for Therapists

• A medication referral is not a failure of therapy. It is an expansion of the treatment team.
• Seven key indicators warrant referral: treatment plateau, severity escalation, neurovegetative symptoms, safety concerns, complex comorbidities, prior medication response, and significant family psychiatric history.
• How you frame the referral conversation matters as much as the clinical decision itself.
• Invest in finding psychiatry partners who communicate well, value psychotherapy, and are accessible.
• Build referral workflows into your practice systems so you are prepared when the need arises.
• When in doubt, refer sooner rather than later.

About the Author: Dr. Ronald Lee is a board-certified psychiatrist practicing telepsychiatry in Massachusetts. He partners with therapists across the state for collaborative medication management.